S. Vukelja
Impact in
- Oncology top 5%
- Neutropenia and Cancer Infections
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 8
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 4
-
- Advanced Breast Cancer Therapies 3
- Co-authors
- Joyce O’Shaughnessy (7 shared papers)Stephen E. Jones (3 shared papers)Frankie A. Holmes (2 shared papers)Israel Wiznitzer (1 shared paper)Luís Meza (1 shared paper)Lister Hill (1 shared paper)J. Shogan (1 shared paper)Theresa Neumann (1 shared paper)
- Journals
- Journal of Clinical Oncology (12 papers)Cancer Research (4 papers)Breast Cancer Research and Treatment (1 paper)Annals of Hematology (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesItalyIndia
In The Last Decade
S. Vukelja
25 papers receiving 571 citations
Peers
Comparison fields: 5 of 53
- Oncology 450
- Hematology 79
- Dermatology 54
- Genetics 155
- Emergency Medicine 32
Countries citing papers authored by S. Vukelja
This map shows the geographic impact of S. Vukelja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Vukelja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Vukelja more than expected).
Fields of papers citing papers by S. Vukelja
This network shows the impact of papers produced by S. Vukelja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Vukelja. The network helps show where S. Vukelja may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Vukelja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 448 | |
| 2 | 2009 | 21 | |
| 3 | 1997 | 21 | |
| 4 | 2007 | 11 | |
| 5 | 2005 | 11 | |
| 6 | Lymphomatoid Papulosis Associated with Ki-1-Positive Anaplastic Large Cell Lymphoma. | 1994 | 10 |
| 7 | 2011 | 9 | |
| 8 | 2005 | 9 | |
| 9 | 2009 | 8 | |
| 10 | 2010 | 8 | |
| 11 | 1995 | 7 | |
| 12 | Xeloda (capecitabine) plus docetaxel combination therapy in locally advanced/metastatic breast cancer: Latest results | 2001 | 6 |
| 13 | 1990 | 6 | |
| 14 | 2001 | 6 | |
| 15 | 1992 | 5 | |
| 16 | 2007 | 4 | |
| 17 | 2009 | 3 | |
| 18 | 2011 | 2 | |
| 19 | 2004 | 2 | |
| 20 | 2009 | 1 |
About S. Vukelja
S. Vukelja is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Genetics and Cancer Research, having authored 25 papers that have together received 603 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), HER2/EGFR in Cancer Research (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Advanced Breast Cancer Therapies (3 papers), Breast Cancer Treatment Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Estrogen and related hormone effects (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). The work is most often cited by research in Oncology (450 citations), Hematology (79 citations), Dermatology (54 citations), Genetics (155 citations) and Emergency Medicine (32 citations). S. Vukelja has collaborated with scholars based in United States, Italy and India. Frequent co-authors include Joyce O’Shaughnessy, Stephen E. Jones, Frankie A. Holmes, Israel Wiznitzer, Luís Meza, Lister Hill, J. Shogan, Theresa Neumann, Bertrand C. Liang and Michael A. Savin. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Breast Cancer Research and Treatment, Annals of Hematology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.